The global cancer/tumor profiling market size is expected to
reach USD 21.08 billion by 2025, exhibiting a CAGR of 8.8%, according to a new
report by Grand View Research, Inc. Rising research in the application of omics
sciences in cancer detection is anticipated to influence market growth.
Technological advances in biotechnology have
allowed for deeper insights into metabolism and gene expression. These have accelerated
the application of advanced techniques such as metabolomics and epigenetics in
cancer screening and detection. Thus, demand for cancer tumor/profiling (CTP)
techniques is anticipated to witness lucrative growth with the expansion of
downstream applications.
Cancer tumor profiling is a potential
procedure through which cancer can be detected and studied further to identify
the stage, metabolism, and changes in morphology of the tumor. This aids in
routine diagnostics as well as therapeutic decision-making. Tumor profiling has
significant importance in developing therapies aimed at a specific individual,
based on the severity of ailment and genomic build up of the individual.
Enhanced detection and sequencing techniques
such as NGS and in-situ hybridization can help speed up the cancer tumor
profiling process and are estimated to gain much traction over the coming
years. Their high adoption is attributive to accelerated speed in gaining
results with minimum resources and greater accuracy.
For full research report on Cancer/Tumor
Profiling Market visit here: https://www.grandviewresearch.com/industry-analysis/cancer-tumor-profiling-market
Further key
findings from the report suggest:
- Personalized cancer
medicine is expected to be the most lucrative application segment for CTP
adoption. The segment is expected to fuel exhibit a CAGR of over 9.0%
- Owing to difference
in usage of and interdependency of functional information from genomic,
epigenomic, and metabolomic analysis of cancer cells, it can be expected
that these technology segments will grow in tandem with each other and
exhibit lucrative growth over the forecast years
- Asia Pacific is
projected to witness substantial growth over the next decade owing to
various developments across major economies, with increased focus of
dominant players in emerging economies as well
- Key players include
Illumina, Inc.; Qiagen N.V.; Neogenomics Laboratories Inc.; HTG Molecular
Diagnostics, Inc.; Genomic Health Inc.; Caris Life Sciences Helomics
Corporation; Nanostring Technologies; Oxford Gene Technology; Ribomed
Biotechnologies, Inc.; Personal Genome Diagnostics; GenomeDX; Guardant
Health; and Foundation Medicine.
Get request sample of this report here: https://www.grandviewresearch.com/industry-analysis/cancer-tumor-profiling-market/request/rs1
Grand
View Research has segmented the global cancer/tumor profiling market on the
basis of technology, technique, application, and region:
Cancer/Tumor
Profiling Technique Outlook (Revenue, USD Million, 2014 - 2025)
- Genomics
- Proteomics
- Metabolomics
- Epigenetics
Cancer/Tumor
Profiling Technology Outlook (Revenue, USD Million, 2014 - 2025)
- Sequencing
Techniques
- Next-generation
Sequencing
- Sanger Sequencing
- Pyro Sequencing
- In Situ
Hybridization
- Immunohistochemistry
- Quantitative PCR
- Microarray
Cancer/Tumor
Profiling Application Outlook (Revenue, USD Million, 2014 - 2025)
- Personalized Cancer
Medicine
- Oncological
Diagnostics
- Research
- Cancer Research
- Biomarker Discovery
Cancer/Tumor
Profiling Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- Asia Pacific
- China
- Japan
- Latin America
- Brazil
- Middle East &
Africa
- South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, we offer market intelligence studies ensuring
relevant and fact-based research across a range of industries, from technology
to chemicals, materials and healthcare.
No comments:
Post a Comment